These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 6128272)

  • 21. Soluble human leukocyte antigen-G isoforms in maternal plasma in early and late pregnancy.
    Rizzo R; Andersen AS; Lassen MR; Sørensen HC; Bergholt T; Larsen MH; Melchiorri L; Stignani M; Baricordi OR; Hviid TV
    Am J Reprod Immunol; 2009 Nov; 62(5):320-38. PubMed ID: 19811467
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of uric acid with progression to preeclampsia and development of adverse conditions in gestational hypertensive pregnancies.
    Wu Y; Xiong X; Fraser WD; Luo ZC
    Am J Hypertens; 2012 Jun; 25(6):711-7. PubMed ID: 22378034
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hemorheological parameters in the prognosis of the risk of fetal retardation in pregnancy with arterial hypertension].
    Stoev S; Dikov I; Iovchev S; Ivanov S
    Akush Ginekol (Sofiia); 1996; 35(4):23-4. PubMed ID: 9254562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolactin in hypertensive pregnancy.
    Redman CW; Bonnar J; Beilin LJ; McNeilly AS
    Br Med J; 1975 Feb; 1(5953):304-6. PubMed ID: 1111791
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Plasminogen activator of urokinase type and its inhibitor of placental type in hypertensive pregnancies and in intrauterine growth retardation: possible markers of placental function.
    Lindoff C; Astedt B
    Am J Obstet Gynecol; 1994 Jul; 171(1):60-4. PubMed ID: 8030735
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical utility of serum uric acid measurements in pre-eclampsia and transient hypertension in pregnancy.
    D'Anna R; Baviera G; Scilipoti A; Leonardi I; Leo R
    Panminerva Med; 2000 Jun; 42(2):101-3. PubMed ID: 10965770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. sCD40 ligand determined in maternal and umbilical cord blood in pregnancies complicated by pre-eclampsia with and without intrauterine growth retardation.
    Laskowska M; Laskowska K; Leszczyńska-Gorzelak B; Oleszczuk J
    Gynecol Obstet Invest; 2007; 64(1):8-13. PubMed ID: 17199090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Maternal serum transforming growth factor beta-2 in preeclampsia and eclampsia, a potential biomarker for the assessment of disease severity and fetal outcome.
    Shaarawy M; El Meleigy M; Rasheed K
    J Soc Gynecol Investig; 2001; 8(1):27-31. PubMed ID: 11223354
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated circulating homocyst(e)ine levels in placental vascular disease and associated pre-eclampsia.
    Wang J; Trudinger BJ; Duarte N; Wilcken DE; Wang XL
    BJOG; 2000 Jul; 107(7):935-8. PubMed ID: 10901568
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders.
    D'Antona D; Reis FM; Benedetto C; Evans LW; Groome NP; de Kretser DM; Wallace EM; Petraglia F
    J Endocrinol; 2000 Apr; 165(1):157-62. PubMed ID: 10750046
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Poor predictive value of platelet count, mean platelet volume and serum urate in hypertension in pregnancy.
    Calvert SM; Tuffnell DJ; Haley J
    Eur J Obstet Gynecol Reprod Biol; 1996 Feb; 64(2):179-84. PubMed ID: 8819999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. First trimester uric acid and adverse pregnancy outcomes.
    Laughon SK; Catov J; Powers RW; Roberts JM; Gandley RE
    Am J Hypertens; 2011 Apr; 24(4):489-95. PubMed ID: 21252861
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypertension in pregnancy: maternal and fetal outcomes according to laboratory and clinical features.
    Brown MA; Buddle ML
    Med J Aust; 1996 Oct; 165(7):360-5. PubMed ID: 8890841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are high uric acid levels in patients with early pre-eclampsia an indication for delivery?
    Odendaal HJ; Pienaar ME
    S Afr Med J; 1997 Feb; 87(2):213-8. PubMed ID: 9180815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in serum concentrations of inhibin in early onset pre-eclampsia with intrauterine growth restriction.
    Itoh Y; Suzuki Y; Yamamoto T; Kojima K; Murakami I; Suzumori N
    J Obstet Gynaecol Res; 2006 Feb; 32(1):80-5. PubMed ID: 16445530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Maternal plasma alpha-fetoprotein in normal and complicated pregnancies.
    Rodeck CH; Campbell S; Biswas S
    Br J Obstet Gynaecol; 1976 Jan; 83(1):24-32. PubMed ID: 56194
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of maternal levels of blood glucose on fetal outcome.
    Raman L; Rao VA; Kumar S
    Int J Gynaecol Obstet; 1982 Oct; 20(5):363-9. PubMed ID: 6128268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proteinuria and outcome of 444 pregnancies complicated by hypertension.
    Ferrazzani S; Caruso A; De Carolis S; Martino IV; Mancuso S
    Am J Obstet Gynecol; 1990 Feb; 162(2):366-71. PubMed ID: 2309816
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma concentration of urate, urea and creatinine in Nigerian primigravidae with pre-eclampsia.
    Egwuatu VE
    Trop Geogr Med; 1986 Mar; 38(1):11-5. PubMed ID: 3961905
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The usefulness of routine laboratory tests in the evaluation of sudden threat of pregnant woman and fetus in pre-eclampsia].
    Malarewicz A; Gruszka O; Szymkiewicz J; Rogala J
    Ginekol Pol; 2006 Apr; 77(4):276-84. PubMed ID: 16875033
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.